Walleye Capital
DXCM icon

Walleye Capital’s DexCom DXCM Stock Holding History

Walleye Capital’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.2K Buy
225
+208
+1,224% +$13.9K ﹤0.01% 4442
2026
Q1 		$1.07K Sell
17
-924,645
-100% -$64.4M ﹤0.01% 4260
2025
Q4 		$61.4M Buy
924,662
+125,922
+16% +$8.14M 0.19% 43
2025
Q3 		$53.7M Buy
798,740
+502,484
+170% +$39.8M 0.2% 55
2025
Q2 		$25.9M Buy
296,256
+44,784
+18% +$3.51M 0.1% 161
2025
Q1 		$17.2M Buy
251,472
+102,526
+69% +$8.37M 0.08% 249
2024
Q4 		$11.6M Sell
148,946
-218,911
-60% -$16.2M 0.03% 544
2024
Q3 		$24.7M Buy
367,857
+179,392
+95% +$14.7M 0.05% 265
2024
Q2 		$21.4M Buy
188,465
+36,387
+24% +$4.6M 0.04% 334
2024
Q1 		$21.1M Buy
152,078
+57,416
+61% +$7.22M 0.04% 398
2023
Q4 		$11.7M Sell
94,662
-117,521
-55% -$12M 0.02% 593
2023
Q3 		$19.8M Buy
+212,183
New +$23.9M 0.05% 265
2022
Q4 		– Sell
-6,041
Closed -$487K – 3287
2022
Q3 		$487K Sell
6,041
-11,955
-66% -$1.01M 0.01% 1489
2022
Q2 		$1.34M Buy
+17,996
New +$1.64M 0.04% 502
2022
Q1 		– Sell
-7,392
Closed -$992K – 2360
2021
Q4 		$992K Buy
7,392
+824
+13% +$118K 0.03% 599
2021
Q3 		$898K Buy
+6,568
New +$828K 0.03% 504
2020
Q3 		– Sell
-5,740
Closed -$582K – 867
2020
Q2 		$582K Sell
5,740
-1,180
-17% -$106K 0.13% 200
2020
Q1 		$466K Sell
6,920
-3,480
-33% -$217K 0.1% 243
2019
Q4 		$569K Buy
+10,400
New +$493K 0.04% 618
2019
Q3 		– Sell
-9,480
Closed -$355K – 1966
2019
Q2 		$355K Sell
9,480
-1,244
-12% -$39.1K 0.04% 658
2019
Q1 		$319K Buy
+10,724
New +$377K 0.05% 573

Other funds holding DXCM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Walleye Capital's DXCM Position: Q2 2026 in Review

Walleye Capital increased its DexCom (DXCM) stake by 1,224% in Q2 2026, buying an estimated $13.9K and bringing the position to 225 shares worth $15.2K. The position accounts for ﹤0.01% of the portfolio, ranked #4442.

Walleye Capital first reported a position in DXCM in Q1 2019 and has held it in 21 quarters since. The position peaked at $61.4M in Q4 2025. 973 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Walleye Capital held 225 shares of DexCom worth $15.2K as of Q2 2026.
  • Walleye Capital bought 208 DexCom shares in Q2 2026, an estimated $13.9K.
  • DexCom made up ﹤0.01% of Walleye Capital's portfolio in Q2 2026, its #4442 holding.
  • Walleye Capital first reported a position in DexCom in Q1 2019 and has held it in 21 quarters since.
  • Walleye Capital's DexCom position peaked at $61.4M in Q4 2025.
  • 973 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.